T. Rowe Price Investment Management
MGNX icon

T. Rowe Price Investment Management’s MacroGenics MGNX Stock Holding History

T. Rowe Price Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,767,034
Closed -$40.7M – 644
2024
Q1 		$40.7M Sell
2,767,034
-2,872,960
-51% -$43.4M 0.02% 426
2023
Q4 		$54.3M Buy
5,639,994
+148,042
+3% +$1.02M 0.04% 384
2023
Q3 		$25.6M Buy
5,491,952
+29,300
+0.5% +$146K 0.02% 456
2023
Q2 		$29.2M Buy
5,462,652
+2,549,247
+88% +$15.7M 0.02% 441
2023
Q1 		$20.9M Buy
2,913,405
+36,677
+1% +$221K 0.02% 467
2022
Q4 		$19.3M Sell
2,876,728
-5,281
-0.2% -$29K 0.01% 462
2022
Q3 		$9.97M Buy
+2,882,009
New +$11M 0.01% 498

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management's MGNX Position: Q2 2024 in Review

T. Rowe Price Investment Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 2,767,034 shares — an estimated $40.7M sold.

T. Rowe Price Investment Management first reported a position in MGNX in Q3 2022 and held it in 7 quarters. The position peaked at $54.3M in Q4 2023. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • T. Rowe Price Investment Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,767,034 MacroGenics shares in Q2 2024, an estimated $40.7M.
  • T. Rowe Price Investment Management first reported a position in MacroGenics in Q3 2022 and held it in 7 quarters.
  • T. Rowe Price Investment Management's MacroGenics position peaked at $54.3M in Q4 2023.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.